Carregant...
Overexpression/amplification of HER-2/neu is uncommon in hepatocellular carcinoma
Background: Hepatocellular carcinoma (HCC) is one of the most prevalent fatal cancers in the world. Despite advances in early diagnosis and improvements in surgical techniques, the survival of patients with HCC even after resection is poor because of the high incidence of recurrences. Therefore, the...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Copyright 2005 Journal of Clinical Pathology
2005
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1770655/ https://ncbi.nlm.nih.gov/pubmed/15858121 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jcp.2004.023556 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|